Free Trial

Campari Group (CPRIM: unrated) says US spirits weakness lingers

CONSUMER STAPLES
  • Campari CEO flagged continuing US weakness into the 3Q on Friday and later clarified it was in reference to the whole sector not company. It saw a firmer +3.5% growth in 1H US sales vs. Pernod -9% (year to June) and Diageo -3% (year to June). Its stock closed -6% and peers Diageo (-2%) & Pernod Ricard (-3%) were weak (SXXP +0.8%).
  • We are cautious on the sector after weak trends and open ended guidance. Still Diageo priced 3-part next to AB-Inbev curve late last month - which surprised us (AB-Inbev is wide moat; largest & highest margin brewer).
  • Guidance from the 3 spirit players below and please note the pending brewer/Carlsberg M&A supply- we expect £1.8b cash short-fall (financed through a bridge facility) to be refi'd eventually.

    • Pernod; FY organic sales to reverse back to growth (after organic -1%/reported -4% to June) and sustain organic EBIT margin (28.4% last year, +80bps yoy).
    • Campari; Outperform industry but ability to expand gross margin will be limited. It will roll over (from 2H last year) a gross 56.7% and adj. EBIT 17.7% margin.
    • Diageo; consumer environment continuing to be challenging - when it improves we will see organic net sales return (reported -0.6% on -3.5% volume fall for year ending June). Expects EBIT margin pressure to continue (contracted -130bps to 29.6% in year ending June).
223 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.
  • Campari CEO flagged continuing US weakness into the 3Q on Friday and later clarified it was in reference to the whole sector not company. It saw a firmer +3.5% growth in 1H US sales vs. Pernod -9% (year to June) and Diageo -3% (year to June). Its stock closed -6% and peers Diageo (-2%) & Pernod Ricard (-3%) were weak (SXXP +0.8%).
  • We are cautious on the sector after weak trends and open ended guidance. Still Diageo priced 3-part next to AB-Inbev curve late last month - which surprised us (AB-Inbev is wide moat; largest & highest margin brewer).
  • Guidance from the 3 spirit players below and please note the pending brewer/Carlsberg M&A supply- we expect £1.8b cash short-fall (financed through a bridge facility) to be refi'd eventually.

    • Pernod; FY organic sales to reverse back to growth (after organic -1%/reported -4% to June) and sustain organic EBIT margin (28.4% last year, +80bps yoy).
    • Campari; Outperform industry but ability to expand gross margin will be limited. It will roll over (from 2H last year) a gross 56.7% and adj. EBIT 17.7% margin.
    • Diageo; consumer environment continuing to be challenging - when it improves we will see organic net sales return (reported -0.6% on -3.5% volume fall for year ending June). Expects EBIT margin pressure to continue (contracted -130bps to 29.6% in year ending June).